$3.23
0.020.62%
Pre-Market: 7:54 PM EDT
15 minutes delayed
Comments
Loading...
Cerence
CRNCNASDAQ
want to know what
the Bulls & Bears Say?
Cerence (NASDAQ:CRNC) Stock, Analyst Ratings, Price Targets, Forecasts
Cerence Inc has a consensus price target of $34.04 based on the ratings of 14 analysts. The high is $135 issued by Baird on August 10, 2021. The low is $3 issued by Goldman Sachs on July 10, 2024. The 3 most-recent analyst ratings were released by Evercore ISI Group, Baird, and Goldman Sachs on July 15, 2024, July 12, 2024, and July 10, 2024, respectively. With an average price target of $4.67 between Evercore ISI Group, Baird, and Goldman Sachs, there's an implied 44.48% upside for Cerence Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Evercore ISI Group
Baird
Goldman Sachs
Craig-Hallum
Wedbush
1calculated from analyst ratings
Analyst Ratings for Cerence
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/15/2024 | Buy Now | 54.8% | Evercore ISI Group | Chris McNally | $8 → $5 | Maintains | In-Line | Get Alert |
| 07/12/2024 | Buy Now | 85.76% | Baird | Luke Junk | $8 → $6 | Maintains | Neutral | Get Alert |
| 07/10/2024 | Buy Now | -7.12% | Goldman Sachs | Mark Delaney | $6 → $3 | Maintains | Neutral | Get Alert |
| 05/13/2024 | Buy Now | 85.76% | Goldman Sachs | Mark Delaney | $19 → $6 | Maintains | Neutral | Get Alert |
| 05/10/2024 | Buy Now | 147.68% | Craig-Hallum | Jeff Van Rhee | $22 → $8 | Maintains | Hold | Get Alert |
| 05/10/2024 | Buy Now | 178.64% | Wedbush | Daniel Ives | $21 → $9 | Maintains | Neutral | Get Alert |
| 05/10/2024 | Buy Now | 101.24% | Wells Fargo | Colin Langan | $25 → $6.5 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 05/10/2024 | Buy Now | 147.68% | Baird | Luke Junk | $15 → $8 | Maintains | Neutral | Get Alert |
| 05/10/2024 | Buy Now | — | Needham | Quinn Bolton | — | Reiterates | → Hold | Get Alert |
| 05/07/2024 | Buy Now | — | Needham | Quinn Bolton | — | Downgrade | Buy → Hold | Get Alert |
| 04/17/2024 | Buy Now | 364.4% | Baird | Luke Junk | $17 → $15 | Maintains | Neutral | Get Alert |
| 03/15/2024 | Buy Now | 612.07% | Needham | Quinn Bolton | → $23 | Reiterates | Buy → Buy | Get Alert |
| 02/07/2024 | Buy Now | 581.11% | Craig-Hallum | Jeff Van Rhee | → $22 | Downgrade | Buy → Hold | Get Alert |
| 02/07/2024 | Buy Now | 550.15% | Wedbush | Daniel Ives | $19 → $21 | Maintains | Neutral | Get Alert |
| 11/29/2023 | Buy Now | 488.24% | Goldman Sachs | Mark Delaney | $28 → $19 | Maintains | Neutral | Get Alert |
| 11/28/2023 | Buy Now | 673.99% | Craig-Hallum | Jeff Van Rhee | $38 → $25 | Maintains | Buy | Get Alert |
| 11/28/2023 | Buy Now | 673.99% | Wells Fargo | Colin Langan | $32 → $25 | Maintains | Overweight | Get Alert |
| 11/28/2023 | Buy Now | 488.24% | Wedbush | Daniel Ives | $31 → $19 | Maintains | Neutral | Get Alert |
| 11/28/2023 | Buy Now | 612.07% | Needham | Quinn Bolton | $34 → $23 | Maintains | Buy | Get Alert |
| 05/11/2023 | Buy Now | 704.95% | Wedbush | Daniel Ives | $32 → $26 | Maintains | Neutral | Get Alert |
| 05/10/2023 | Buy Now | 1200.31% | Needham | Rajvindra Gill | → $42 | Reiterates | → Buy | Get Alert |
| 03/03/2023 | Buy Now | 1200.31% | Needham | Rajvindra Gill | → $42 | Reiterates | → Buy | Get Alert |
| 02/10/2023 | Buy Now | 890.71% | Wedbush | Daniel Ives | $25 → $32 | Maintains | Neutral | Get Alert |
| 02/09/2023 | Buy Now | 859.75% | Goldman Sachs | Mark Delaney | $19 → $31 | Maintains | Neutral | Get Alert |
| 02/09/2023 | Buy Now | 1138.39% | Craig-Hallum | Jeff Van Rhee | → $40 | Upgrade | Hold → Buy | Get Alert |
| 02/09/2023 | Buy Now | 828.79% | Baird | Luke Junk | $23 → $30 | Maintains | Neutral | Get Alert |
| 02/09/2023 | Buy Now | 890.71% | Wells Fargo | Colin Langan | $25 → $32 | Maintains | Overweight | Get Alert |
| 02/09/2023 | Buy Now | 1200.31% | Needham | Rajvindra Gill | $40 → $42 | Maintains | Buy | Get Alert |
| 11/30/2022 | Buy Now | 488.24% | Goldman Sachs | Mark Delaney | $17 → $19 | Maintains | Neutral | Get Alert |
| 11/30/2022 | Buy Now | 1138.39% | Needham | Rajvindra Gill | $30 → $40 | Maintains | Buy | Get Alert |
| 11/15/2022 | Buy Now | 673.99% | Wells Fargo | Colin Langan | $48 → $25 | Maintains | Overweight | Get Alert |
| 10/11/2022 | Buy Now | 426.32% | Goldman Sachs | Chris Merwin | $30 → $17 | Maintains | Neutral | Get Alert |
| 08/10/2022 | Buy Now | 828.79% | Goldman Sachs | Chris Merwin | $34 → $30 | Maintains | Neutral | Get Alert |
| 08/10/2022 | Buy Now | 581.11% | RBC Capital | Joseph Spak | $27 → $22 | Maintains | Sector Perform | Get Alert |
| 08/10/2022 | Buy Now | — | Craig-Hallum | Jeff Van Rhee | — | Downgrade | Buy → Hold | Get Alert |
| 08/10/2022 | Buy Now | 1386.07% | Wells Fargo | Colin Langan | $64 → $48 | Maintains | Overweight | Get Alert |
| 08/10/2022 | Buy Now | — | Raymond James | Brian Gesuale | — | Downgrade | Outperform → Market Perform | Get Alert |
| 08/10/2022 | Buy Now | 828.79% | Needham | Rajvindra Gill | $46 → $30 | Maintains | Buy | Get Alert |
| 07/11/2022 | Buy Now | 1881.42% | Wells Fargo | Colin Langan | $66 → $64 | Maintains | Overweight | Get Alert |
| 07/07/2022 | Buy Now | 735.91% | RBC Capital | Joseph Spak | $28 → $27 | Upgrade | Underperform → Sector Perform | Get Alert |
| 05/12/2022 | Buy Now | 952.63% | Goldman Sachs | Chris Merwin | $44 → $34 | Maintains | Neutral | Get Alert |
| 05/11/2022 | Buy Now | 1943.34% | Wells Fargo | Colin Langan | $67 → $66 | Maintains | Overweight | Get Alert |
| 05/11/2022 | Buy Now | 766.87% | RBC Capital | Joseph Spak | $34 → $28 | Maintains | Underperform | Get Alert |
| 05/11/2022 | Buy Now | 1324.15% | Needham | Rajvindra Gill | $78 → $46 | Maintains | Buy | Get Alert |
| 04/01/2022 | Buy Now | 1974.3% | Wells Fargo | Colin Langan | $68 → $67 | Maintains | Overweight | Get Alert |
| 02/22/2022 | Buy Now | 1262.23% | Goldman Sachs | Chris Merwin | → $44 | Downgrade | Buy → Neutral | Get Alert |
| 02/14/2022 | Buy Now | 1602.79% | Evercore ISI Group | Chris McNally | → $55 | Downgrade | Outperform → In-Line | Get Alert |
| 02/09/2022 | Buy Now | 2314.86% | Needham | Rajvindra Gill | $165 → $78 | Maintains | Buy | Get Alert |
| 02/08/2022 | Buy Now | 1293.19% | Wedbush | Daniel Ives | $115 → $45 | Downgrade | Outperform → Neutral | Get Alert |
| 02/08/2022 | Buy Now | 1138.39% | Jefferies | David Kelley | → $40 | Downgrade | Buy → Hold | Get Alert |
| 02/08/2022 | Buy Now | 1447.99% | Baird | Luke Junk | → $50 | Downgrade | Outperform → Neutral | Get Alert |
| 02/08/2022 | Buy Now | 1045.51% | RBC Capital | Joseph Spak | → $37 | Downgrade | Sector Perform → Underperform | Get Alert |
| 02/08/2022 | Buy Now | 2252.94% | Raymond James | Brian Gesuale | $100 → $76 | Maintains | Outperform | Get Alert |
| 01/14/2022 | Buy Now | 2283.9% | RBC Capital | Joseph Spak | $95 → $77 | Downgrade | Outperform → Sector Perform | Get Alert |
| 01/10/2022 | Buy Now | 3088.85% | Goldman Sachs | Chris Merwin | $115 → $103 | Maintains | Buy | Get Alert |
| 12/16/2021 | Buy Now | 2531.58% | Wells Fargo | Colin Langan | — | Upgrade | Equal-Weight → Overweight | Get Alert |
| 12/07/2021 | Buy Now | 2995.98% | Raymond James | Brian Gesuale | — | Upgrade | Market Perform → Outperform | Get Alert |
| 11/23/2021 | Buy Now | 3460.37% | Wedbush | Daniel Ives | — | Maintains | Outperform | Get Alert |
| 11/23/2021 | Buy Now | 3460.37% | Goldman Sachs | — | — | Maintains | Buy | Get Alert |
| 11/23/2021 | Buy Now | 2717.34% | Wells Fargo | Colin Langan | — | Maintains | Equal-Weight | Get Alert |
| 11/23/2021 | Buy Now | 2841.18% | RBC Capital | Joseph Spak | — | Maintains | Outperform | Get Alert |
| 10/06/2021 | Buy Now | 3305.57% | RBC Capital | Joseph Spak | — | Upgrade | Sector Perform → Outperform | Get Alert |
| 10/05/2021 | Buy Now | 2841.18% | Wells Fargo | Colin Langan | — | Maintains | Equal-Weight | Get Alert |
| 09/10/2021 | Buy Now | 3398.45% | Wells Fargo | Colin Langan | — | Maintains | Equal-Weight | Get Alert |
| 08/16/2021 | Buy Now | 4543.96% | Evercore ISI Group | Chris McNally | — | Maintains | Outperform | Get Alert |
| 08/10/2021 | Buy Now | 4079.57% | Baird | — | — | Maintains | Outperform | Get Alert |
| 08/10/2021 | Buy Now | 3460.37% | Wells Fargo | Colin Langan | — | Maintains | Equal-Weight | Get Alert |
| 08/10/2021 | Buy Now | 4389.16% | Craig-Hallum | Jeff Van Rhee | — | Maintains | Buy | Get Alert |
| 08/10/2021 | Buy Now | 3429.41% | RBC Capital | Joseph Spak | — | Maintains | Sector Perform | Get Alert |
| 08/10/2021 | Buy Now | 5008.36% | Needham | Rajvindra Gill | — | Maintains | Buy | Get Alert |
FAQ
What is the target price for Cerence (CRNC) stock?
The latest price target for Cerence (NASDAQ:CRNC) was reported by Evercore ISI Group on July 15, 2024. The analyst firm set a price target for $5.00 expecting CRNC to rise to within 12 months (a possible 54.80% upside). 19 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Cerence (CRNC)?
The latest analyst rating for Cerence (NASDAQ:CRNC) was provided by Evercore ISI Group, and Cerence maintained their in-line rating.
When was the last upgrade for Cerence (CRNC)?
The last upgrade for Cerence Inc happened on February 9, 2023 when Craig-Hallum raised their price target to $40. Craig-Hallum previously had a hold for Cerence Inc.
When was the last downgrade for Cerence (CRNC)?
The last downgrade for Cerence Inc happened on May 10, 2024 when Wells Fargo changed their price target from $25 to $6.5 for Cerence Inc.
When is the next analyst rating going to be posted or updated for Cerence (CRNC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cerence, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cerence was filed on July 15, 2024 so you should expect the next rating to be made available sometime around July 15, 2025.
Is the Analyst Rating Cerence (CRNC) correct?
While ratings are subjective and will change, the latest Cerence (CRNC) rating was a maintained with a price target of $8.00 to $5.00. The current price Cerence (CRNC) is trading at is $3.23, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.